Histogen Inc (HSTO) Stock
HSTO is no longer traded. Histogen was delisted from the Nasdaq in January 2025.
Prices on this page are historical; the last trade was January 7, 2025 at $0.03.
Histogen stock price history
HSTO final trading statistics
- Final close
- $0.03
- Final trading day
- Jan 7, 2025
- Market cap at delisting
- $118.3K
- Shares outstanding
- 4.27M
- Final 52-week range
- $0.02 – $0.55
- Avg. volume (final 3 mo.)
- 1,328
- All-time high (split-adj.)
- $2850.00 · Jan 2014
- All-time low (split-adj.)
- $0.02 · Nov 2024
- Return since IPO
- -100.0%
- Beta
- 1.12
- Book value / share
- $1.27
- Price / book
- 0.02
Histogen annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $19.0K | -$12.4M | — |
| FY2022 | $3.77M | -$10.5M | -$3.37 |
| FY2021 | $919.0K | -$14.4M | -$8.00 |
| FY2020 | $2.06M | -$25.8M | -$42.00 |
| FY2019 | $11.30M | -$4.9M | -$52.80 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Histogen Inc
Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.
Histogen stock FAQ
What happened to Histogen stock?
Histogen stock was delisted from the Nasdaq. Its final close was $0.03 on January 7, 2025.
Is HSTO stock still trading?
No. HSTO was delisted from the Nasdaq in January 2025 and no longer trades on a U.S. exchange.
What was the last price of HSTO stock?
HSTO closed at $0.03 on its final trading day, January 7, 2025, for a market value of about $118.3K.
What were Histogen's revenue and earnings in its last full fiscal year?
Histogen reported revenue of $19.0K and net income of -$12.4M in fiscal 2023, its last full year as a public company.
When did Histogen go public?
Histogen Inc stock began trading on July 25, 2013.